These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 36074324)

  • 1. METTL3 m6A-dependently promotes miR-21-5p maturation to accelerate choriocarcinoma progression via the HIF1AN-induced inactivation of the HIF1A/VEGF pathway.
    Ye K; Li L; Wu B; Wang D
    Genes Genomics; 2022 Nov; 44(11):1311-1322. PubMed ID: 36074324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methyltransferase-like 3 (METTL3) mediated N6-methyladenosine (m6A) modifications facilitate mir-25-3p maturation to promote gastrointestinal stromal tumors (GISTs) progression.
    Qian K; Xu W; Xia X; Ding J
    Genes Genomics; 2022 Dec; 44(12):1519-1530. PubMed ID: 36040683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. METTL3 promotes choriocarcinoma progression by activating the miR-935/GJA1 pathway in an m6A-dependent manner.
    Wang W; Shi J; Zheng L
    Am J Reprod Immunol; 2023 Nov; 90(5):e13791. PubMed ID: 37881126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. METTL3-Mediated Maturation of miR-99a-5p Promotes Cell Migration and Invasion in Oral Squamous Cell Carcinoma by Targeting ZBTB7A.
    Huang Y; Guan Y; Zhang X
    Mol Biotechnol; 2024 Aug; 66(8):1942-1953. PubMed ID: 37498409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of methyltransferase like 3 in epithelial-mesenchymal transition process, invasion, and metastasis in esophageal cancer.
    Liang X; Zhang Z; Wang L; Zhang S; Ren L; Li S; Xu J; Lv S
    Bioengineered; 2021 Dec; 12(2):10023-10036. PubMed ID: 34666602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression.
    Li S; Lu X; Zheng D; Chen W; Li Y; Li F
    J Cancer Res Clin Oncol; 2022 Dec; 148(12):3485-3499. PubMed ID: 35907010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-methyladenosine-induced miR-182-5p promotes multiple myeloma tumorigenesis by regulating CAMK2N1.
    Bao J; Xu T; Wang W; Xu H; Chen X; Xia R
    Mol Cell Biochem; 2024 Nov; 479(11):3077-3089. PubMed ID: 38180718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3-mediated maturation of miR-589-5p promotes the malignant development of liver cancer.
    Liu J; Jiang K
    J Cell Mol Med; 2022 May; 26(9):2505-2519. PubMed ID: 35348293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in cervical cancer and inhibits growth and metastasis of cervical cancer xenografts by targeting the METTL3/KRAS axis.
    Gong Y; Luo G; Zhang S; Chen Y; Hu Y
    Cell Signal; 2024 May; 117():111068. PubMed ID: 38286198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot Study.
    Huang G; Qiu Y; Fan Y; Liu J
    Neurochem Res; 2024 Jan; 49(1):85-98. PubMed ID: 37610605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3 promotes prostate cancer progression by regulating miR-182 maturation in m6A-dependent manner.
    Wang D; Wang X; Huang B; Zhao Y; Tu W; Jin X; Shao Y; Zhu Y; Lu G
    Andrologia; 2022 Aug; 54(7):1581-1591. PubMed ID: 35413135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL3 is aberrantly expressed in endometriosis and suppresses proliferation, invasion, and migration of endometrial stromal cells.
    Zhang QC
    Kaohsiung J Med Sci; 2023 Mar; 39(3):266-277. PubMed ID: 36546578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methyltransferase-like 3-mediated m6A modification of miR-1908-5p contributes to nasopharyngeal carcinoma progression by targeting homeodomain-only protein homeobox.
    Zhou Y; Li W
    Environ Toxicol; 2024 Mar; 39(3):1631-1640. PubMed ID: 38018881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3-mediated maturation of miR-126-5p promotes ovarian cancer progression via PTEN-mediated PI3K/Akt/mTOR pathway.
    Bi X; Lv X; Liu D; Guo H; Yao G; Wang L; Liang X; Yang Y
    Cancer Gene Ther; 2021 Apr; 28(3-4):335-349. PubMed ID: 32939058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
    Zhao C; Ling X; Xia Y; Yan B; Guan Q
    Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circular RNA circ_KIAA1429 accelerates hepatocellular carcinoma progression via the miR-133a-3p/high mobility group AT-hook 2 (HMGA2) axis in an m6A-dependent manner.
    Zhang CP; Huang XY
    Hum Cell; 2023 Sep; 36(5):1741-1754. PubMed ID: 37368192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway.
    Peng W; Li J; Chen R; Gu Q; Yang P; Qian W; Ji D; Wang Q; Zhang Z; Tang J; Sun Y
    J Exp Clin Cancer Res; 2019 Sep; 38(1):393. PubMed ID: 31492150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL3-mediated m6A modification of pri-miR-148a-3p affects prostate cancer progression by regulating TXNIP.
    Li G; Liu J; Wang Y; Liu H; Fu J; Zhao Y; Huang Y
    Environ Toxicol; 2023 Oct; 38(10):2377-2390. PubMed ID: 37449729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL3 contributes to slow transit constipation by regulating miR-30b-5p/PIK3R2/Akt/mTOR signaling cascade through DGCR8.
    Gong WJ; Li R; Dai QQ; Yu P
    J Gastroenterol Hepatol; 2022 Dec; 37(12):2229-2242. PubMed ID: 36068012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The m6A Methyltransferase METTL3-Mediated N6-Methyladenosine Modification of DEK mRNA to Promote Gastric Cancer Cell Growth and Metastasis.
    Zhang HM; Qi FF; Wang J; Duan YY; Zhao LL; Wang YD; Zhang TC; Liao XH
    Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.